LUNG NON-SMALL CELL CARCINOMA
Clinical trials for LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can grid therapy reboot immunotherapy for lung cancer patients?
Disease control TerminatedThis early-phase study tested whether combining the immunotherapy drug durvalumab with a special type of radiation called grid therapy could help patients with non-small cell lung cancer whose cancer had stopped responding to durvalumab alone. Only 4 patients were enrolled before…
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Light and immune combo shows promise in tough lung cancers
Disease control TerminatedThis early-phase study tested a treatment that uses a light-activated drug (photodynamic therapy) plus immunotherapy to fight non-small cell lung cancer with pleural spread or malignant pleural mesothelioma. Only 5 people took part before the study ended early. The main goal was …
Matched conditions: LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 18, 2026 12:12 UTC